Orthobiologics Market

Orthobiologics sales will rise through 2036, driven by bone graft substitutes at 49.8% of the product type segment in 2026, supported by clinical demand for bone defect repair in spinal fusion and trauma procedures. The market was valued at USD 5.76 billion in 2025 and is expected to be worth USD 8.59 billion by 2036.